Bioactive Lipids in Cancer, Inflammation and Related Diseases
New Orleans, Louisiana
Oct. 30-Nov. 02, 2022
Important Information regarding Covid-19 guidelines. Click here to learn more x
The Eicosanoid Research Foundation presents a Lifetime Achievement Award to individuals who have made significant and ongoing scientific contributions to the field of bioactive lipids and their role in health and disease.
The award winner will be honored at the 2022 International Conference on Bioactive Lipids in Cancer, Inflammation, and Related Disease in New Orleans, Louisiana, scheduled for Oct. 30 – Nov. 2. The awardee will deliver the Lifetime Achievement Award Lecture on the opening day of the conference.
Nominations should include a letter of support from an investigator or group of investigators outlining the candidate’s major contributions, along with his/her curriculum vitae. All nomination material should be sent electronically to the Eicosanoid Research Foundation Board of Directors at info@bioactivelipids.org . The deadline for submission is May 1, 2022.
Bioactive Sphingolipids: Discovery, Foundations, Principles, Developments
Stony Brook University School of Medicine, Stony Brook, New York
Bioactive sphingolipid metabolism and role in disease
Stony Brook University School of Medicine, Stony Brook, New York
Decoding New Lipid Mediators and Mechanisms in Resolution of Inflammation, Infections and Tissue Regeneration
Harvard Medical School and Brigham and Women’s Hospital, Boston, Mass
My adventures in prostaglandin research
Global Center of Excellence Programs, Kyoto University, Kyoto, Japan
Reducing Inflammation by Blocking Interleukin-1
University of Colorado, Division of Infectious Diseases, Aurora, Colo.
Chemistry Biology of cannabinoids and endocannabinoids
Faculty of Medicine, Hebrew University of Jerusalem, Kerem, Jerusalem, Israel
Roles of Leukorienes, formerly known as SRS-A, in asthma and pulmonary disease
Harvard Medical School, and Brigham and Women’s Hospital, Boston, Mass.
Elucidation of the metabolism and biosyntheses of eicosanoids and development of new approaches to quantifying their production in humans
Vanderbilt University School of Medicine, Nashville, Tenn.